Malta
Tuberculosis profile
Population  2012 <1 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) <0.01 (<0.01–<0.01) 0.37 (0.36–0.37)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.03 (0.03–0.04)
Prevalence  (includes HIV+TB) 0.069 (0.032–0.12) 16 (7.5–28)
Incidence  (includes HIV+TB) 0.048 (0.042–0.055) 11 (9.9–13)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.34 (0.3–0.39)
Case detection, all forms (%) 87 (77–99)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 9 (22) Relapse 0 (0)
Smear-negative 10 (24) Treatment after failure 0 (0)
Smear-unknown / not done 10 (24) Treatment after default 0 (0)
Extrapulmonary 12 (29) Other 1 (100)
Other 0 (0)      
Total new 41   Total retreatment 1  
           
Other (history unknown) 1        
Total new and relapse 41   Total cases notified 43  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 3.5 4.0 1.4
Age < 15 1 1 0
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 58   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 79  
Retreatment 100  
TB/HIV 2012 Number (%)
TB patients with known HIV status 42 (98)
HIV-positive TB patients 4 (10)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 0 (0–25) 0 (0–98)
MDR-TB cases among notified pulmonary
TB cases
0 (0–7) 0 (0–1)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 13 (81%) 1 (100%) 14
Laboratory-confirmed MDR-TB cases 0 0 0
Patients started on MDR-TB treatment     0
Financing TB control 2013
National TB programme budget (US$ millions) <1
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-23 Data: www.who.int/tb/data